Bel Marra Health Supports Recent Research that Outlines How Osteoarthritis May be Caused by Mutations in at Least Five Genes in the Cells of the Body

Bel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports recent research that outlines how osteoarthritis may be caused by mutations in a least five genes in the cells of the body.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Bel Marra Health supports recent research that outlines how osteoarthritis may be caused by mutations in a least five genes in the cells of the body

Bel Marra Health supports recent research that outlines how osteoarthritis may be caused by mutations in a least five genes in the cells of the body

CEO for Bel Marra Health Jim Chiang adds, “It is possible to adapt lifestyle changes that may slower the rate of the occurrence of symptoms of osteoarthritis and ultimately prevent its occurrence.”

Toronto, ON (PRWEB) October 12, 2012

Bel Marra Health, well known for offering high-quality, specially formulated vitamins and nutritional supplements, supports recent research that outlines how osteoarthritis may be caused by mutations in a least five genes in the cells of the body.

According to a recent medical report published in the journal Lancet, osteoarthritis may be caused by mutations in a least five genes in the cells of the body. The investigators of the genetic study explained that mutations are tiny changes within the deoxyribonucleic acid (DNA) sequence of the cell, which in turn may trigger modifications in specific proteins that play important roles in the functioning of the body.

The genetic approach conducted in the study involved isolating the DNA from approximately 7,410 patients who were positively diagnosed with osteoarthritis and have been suffering from inflammation, joint stiffness, and pain for several years. These study participants were selected based on the severity of their pain, of which approximately 80% had already undergone joint replacement either in the knee or hip. As control, approximately 11,009 healthy individuals were invited to participate in the genetic screening.

The results of the study showed the GNL3 gene was commonly mutated among the patients with osteoarthritis. This gene is responsible for the production of the nucleostemin protein, which plays a major role in the control of cell division and the maturation of various immature cells. A mutation in the GNL3 gene may thus result in a lack of cells that can replace defective ones, especially the chondrocytes or cartilage cells, which are strongly associated with inflammation of the joints and pain in osteoarthritis.

This result suggested that deterioration of the cartilage and bones of an individual may increase the likelihood of development inflammation and pain, which are hallmark features of osteoarthritis.

Another gene that was identified in the screening assay was the FTO gene, which is responsible for the onset of obesity and fat deposition. Analysis has shown that certain variants of the FTO gene may increase the likelihood of developing not only obesity, but diabetes as well. This gene marker thus strengthens previous medical evidence that excessive weight gain may increase the chances of developing inflammation of the joints, thus resulting in pain and disability.

It is therefore important to regulate the amount of sugar-rich food items that are consumed on a regular basis, to ultimately control weight gain and prevent the occurrence of joint stiffness, pain, and inflammation.

The study also identified the GLT8D1 gene as being commonly mutated among osteoarthritis patients. This gene is responsible for the production of an enzyme called glycosyltransferase, which moves sugar molecules to water, possibly for its excretion or absorption in the body. Spokesperson for Bel Marra Health Dr. Victor Marchione says, “A mutation in this gene may result in a poor capacity to transfer glucose molecules, thus increasing the chances of retaining glucose in the body, which a major symptoms of diabetes. “

The recent medical report has shown that there are a number of genes that are associated with symptoms of osteoarthritis, such as those involving the production of cartilage cells, deposition of fat, and the regulation of body. CEO for Bel Marra Health Jim Chiang adds, “It is possible to adapt lifestyle changes that may slower the rate of the occurrence of symptoms of osteoarthritis and ultimately prevent its occurrence.”

(SOURCE: “The Lancet”, Identification of new susceptibility loci for osteoarthritis (arcOGEN): a genome-wide association study, Sept 7, 2012)

Bel Marra Health, the maker of Joint Rescue, offers high-quality vitamins and nutritional supplements in formulations designed to address specific health concerns. All ingredients are backed with scientific evidence. Every product is tested for safety, quality, and purity at every stage of the manufacturing process. Furthermore, Bel Marra Health products are produced only in Health Canada approved facilities, going that extra mile to ensure our health conscious customers are getting top quality products. For more information on Bel Marra Nutritionals visit http://www.belmarrahealth.com or call 1-866-531-0466.

Bel Marra Nutritionals, Inc.
100-7000 Pine Valley
Woodbridge, ON L4L 4Y8
pr(at)belmarrahealth(dot)com
866-531-0466
http://www.belmarrahealth.com


Contact

Past News Releases Group Rss Subscribe